Bupropion promotes weight loss in overweight women

מתוך medicontext.co.il

By Anthony J. Brown, MD

WESTPORT, CT (Reuters Health) – Bupropion is more effective than placebo in producing weight loss in overweight and obese women, according to a report published in the September issue of Obesity Research.

Premarketing study findings have suggested that sustained-release bupropion produces minor weight loss in a small percentage of subjects with depression. The present study is the first randomized, placebo-controlled trial to show that the drug may be effective in non-depressed, obese subjects, the authors state.

Dr. Kishore M. Gadde, from Duke University Medical Center in Durham, North Carolina, and colleagues randomized 50 non-depressed overweight and obese women to receive bupropion or placebo for 8 weeks. Subjects were prescribed a 1600 kcal/day diet and food diaries were employed to ensure compliance.

The subjects were started on a 100 mg/day dose and gradually increased to a maximum of 200 mg twice daily. Patients who responded to therapy continued treatment for an additional 16 weeks. Additional single-blind follow-up was maintained for a total of 2 years, the authors note.

Over the first 8 weeks, bupropion-treated subjects achieved a mean weight loss of 4.9%, significantly greater than the 1.3% loss achieved by placebo-treated subjects, the investigators state. At the end of the first 8 weeks, the mean weight loss was slightly higher in both groups, but significantly greater weight loss was still noted among bupropion-treated women.

The average weight loss among the 14 bupropion responders who completed 24 weeks of therapy was 12.9% with fat accounting for most of the loss, the researchers note.

"Single-blind follow-up at 1 year revealed a mean weight loss of a little over 14%," Dr. Gadde told Reuters Health. "At 2 years the weight loss was 13.6%," he added. "In most weight loss trials, there is often no further weight loss in the second 6 months of the study and there is often a regain of weight in the second year," he explained. "The fact that this did not occur in the current study is very gratifying."

"We are currently analyzing the 1-year follow-up data of study that involves 327 subjects," Dr. Gadde noted. "So far the results look very positive," he said.

0 תגובות

השאירו תגובה

רוצה להצטרף לדיון?
תרגישו חופשי לתרום!

כתיבת תגובה

מידע נוסף לעיונך

כתבות בנושאים דומים

התכנים המוצגים באתר זה מיועדים לאנשי צוות רפואי בלבד

אם כבר נרשמת, יש להקליד את פרטי הזיהוי שלך